JPH04235976A - Production of aralkylaminopyrimidine compounds - Google Patents
Production of aralkylaminopyrimidine compoundsInfo
- Publication number
- JPH04235976A JPH04235976A JP3073547A JP7354791A JPH04235976A JP H04235976 A JPH04235976 A JP H04235976A JP 3073547 A JP3073547 A JP 3073547A JP 7354791 A JP7354791 A JP 7354791A JP H04235976 A JPH04235976 A JP H04235976A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- alkyl
- atom
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title abstract description 57
- 238000004519 manufacturing process Methods 0.000 title description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 28
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 125000005843 halogen group Chemical group 0.000 claims description 22
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 150000003974 aralkylamines Chemical class 0.000 claims description 4
- 150000003230 pyrimidines Chemical class 0.000 claims description 4
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 2
- -1 pyrimidine compound Chemical class 0.000 abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052736 halogen Inorganic materials 0.000 abstract description 5
- 125000001188 haloalkyl group Chemical group 0.000 abstract description 3
- 229920006395 saturated elastomer Polymers 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 125000004434 sulfur atom Chemical group 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 150000002367 halogens Chemical class 0.000 abstract 4
- 230000001476 alcoholic effect Effects 0.000 abstract 2
- 239000004599 antimicrobial Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 11
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 9
- 229910052801 chlorine Inorganic materials 0.000 description 9
- 125000001309 chloro group Chemical group Cl* 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 229940126062 Compound A Drugs 0.000 description 8
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 8
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 8
- 125000001153 fluoro group Chemical group F* 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000010813 internal standard method Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Chemical group 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- UOXJNGFFPMOZDM-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethylsulfanyl-methylphosphinic acid Chemical compound CC(C)N(C(C)C)CCSP(C)(O)=O UOXJNGFFPMOZDM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- UHWPLNHRROQPMB-UHFFFAOYSA-N [4-(difluoromethoxy)phenyl]methanamine Chemical compound NCC1=CC=C(OC(F)F)C=C1 UHWPLNHRROQPMB-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- RRLWYLINGKISHN-UHFFFAOYSA-N ethoxymethanol Chemical compound CCOCO RRLWYLINGKISHN-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000005694 halopyrimidines Chemical class 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、殺菌剤として有用なア
ラルキルアミノピリミジン類の製法に関するものである
。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing aralkylaminopyrimidines useful as fungicides.
【0002】0002
【従来技術の説明】アラルキルアミノピリミジン類の製
法としては、有機塩基(例えば、トリエチルアミン,ピ
リジンなど)存在下,ハロピリミジン類とアラルキルア
ミン類とを非極性溶媒(例えば、ベンゼン,トルエンな
ど)中で加熱撹拌することによって反応させる方法(特
開昭59−36666号公報)が知られている。しかし
、その製法は反応時間が長く,しかも満足できるような
収率ではないので、アラルキルアミノピリミジン類の工
業的な製法としては適当なものではないという問題があ
る。[Description of the prior art] A method for producing aralkylaminopyrimidines involves combining halopyrimidines and aralkylamines in a nonpolar solvent (e.g., benzene, toluene, etc.) in the presence of an organic base (e.g., triethylamine, pyridine, etc.). A method of reacting by heating and stirring (Japanese Unexamined Patent Publication No. 59-36666) is known. However, this method requires a long reaction time and does not give a satisfactory yield, so it is not suitable as an industrial method for producing aralkylaminopyrimidines.
【0003】0003
【発明が解決すべき課題】本発明の目的は、アラルキル
アミノピリミジン類の工業的な製法を提供することであ
る。SUMMARY OF THE INVENTION An object of the present invention is to provide an industrial method for producing aralkylaminopyrimidines.
【0004】0004
【課題を解決するための手段】本発明者らは、前記の課
題を解決するために鋭意研究した結果、塩基存在下,ピ
リミジン類とアラルキルアミン類とをアルコール溶媒中
で反応させることによって、目的化合物であるアラルキ
ルアミノピリミジン類を短時間で合成することができ,
かつ高収率で得ることができることを見出し、本発明を
完成するに至った。[Means for Solving the Problems] As a result of intensive research in order to solve the above problems, the present inventors have achieved the objective by reacting pyrimidines and aralkylamines in an alcohol solvent in the presence of a base. Aralkylaminopyrimidine compounds can be synthesized in a short time,
The present inventors have discovered that it can be obtained in high yield and have completed the present invention.
【0005】即ち、本発明は、次式の化合物A:That is, the present invention provides a compound A of the following formula:
【化4
】[C4
]
【0006】(式中、R1はハロゲン原子,アルキル基
又は水素原子を表し;R2はアルキル基又はハロゲン原
子を表し;或いは、R1とR2とは、それらが結合して
いる炭素原子と共にピリミジン環に縮合して、硫黄原子
1個を有していてもよい飽和又は不飽和の5もしくは6
員環を形成していてもよく;R3は水素原子,アルキル
基,シクロアルキル基,アルキルチオ基又はアルキル基
で置換していてもよいアミノ基を表し;Xは脱離基を表
す。)で示されるピリミジン類と(In the formula, R1 represents a halogen atom, an alkyl group, or a hydrogen atom; R2 represents an alkyl group or a halogen atom; or R1 and R2 together with the carbon atom to which they are bonded form a pyrimidine ring. Saturated or unsaturated 5 or 6 which may be condensed and have one sulfur atom
It may form a membered ring; R3 represents a hydrogen atom, an alkyl group, a cycloalkyl group, an alkylthio group, or an amino group which may be substituted with an alkyl group; X represents a leaving group; ) and pyrimidines represented by
【0007】次式の化合物B:Compound B of the following formula:
【化5】[C5]
【0008】(式中、R4はアルキル基,ハロアルキル
基,シクロアルキル基又は水素原子を表し;R5はハロ
ゲン原子又は水素原子を表し;R6は水素原子,アルキ
ル基,ハロゲン原子,低級アルコキシ基,ハロアルコキ
シ基を表し;nは1又は2を表し;*を付した炭素原子
は不斉炭素原子である。)で示されるアラルキルアミン
類とをアルコール溶媒中で反応させることを特徴とする
(In the formula, R4 represents an alkyl group, a haloalkyl group, a cycloalkyl group, or a hydrogen atom; R5 represents a halogen atom or a hydrogen atom; R6 represents a hydrogen atom, an alkyl group, a halogen atom, a lower alkoxy group, a halo Represents an alkoxy group; n represents 1 or 2; carbon atoms marked with * are asymmetric carbon atoms) are reacted in an alcohol solvent.
【0009】次式の化合物C:Compound C of the following formula:
【化6】[C6]
【0010】(式中、R1,R2,R3,R4,R5,
R6及びnは前記の記載と同義。)で示されるアラルキ
ルアミノピリミジン類の製法に関するものである。(In the formula, R1, R2, R3, R4, R5,
R6 and n are as defined above. ) The present invention relates to a method for producing aralkylaminopyrimidines represented by the following.
【0011】以下、本発明について詳細に説明する。前
記の目的化合物であるアラルキルアミノピリミジン類〔
化合物C〕、その製造原料であるピリミジン類〔化合物
A〕とアラルキルアミン類〔化合物B〕において、The present invention will be explained in detail below. Aralkylaminopyrimidines which are the target compounds mentioned above [
Compound C], its manufacturing raw materials pyrimidines [Compound A] and aralkylamines [Compound B],
【0
012】R1としては、ハロゲン原子(例えば、塩素原
子,ヨウ素原子,臭素原子,フッ素原子などを挙げるこ
とができる。),アルキル基(例えば、直鎖状又は分岐
状のものを挙げることができるが;好ましくは炭素原子
数1〜8の直鎖状又は分岐状のものがよく;さらに好ま
しくは炭素原子数1〜4の直鎖状のものがよい。),水
素原子などを挙げることができるが;好ましくはハロゲ
ン原子がよく;さらに好ましくは塩素原子,臭素原子な
どがよく;さらに好ましくは塩素原子がよい。0
[012] As R1, a halogen atom (for example, a chlorine atom, an iodine atom, a bromine atom, a fluorine atom, etc.), an alkyl group (for example, a linear or branched one can be mentioned), (preferably linear or branched ones having 1 to 8 carbon atoms; more preferably linear ones having 1 to 4 carbon atoms), hydrogen atoms, etc. Preferably a halogen atom; More preferably a chlorine atom, a bromine atom, etc.; Even more preferably a chlorine atom.
【0013】R2としては、アルキル基(例えば、直鎖
状又は分岐状のものを挙げることができる。),ハロゲ
ン原子(例えば、前記に記載したハロゲン原子を挙げる
ことができるが;好ましくは塩素原子がよい。)などを
挙げることができるが;アルキル基が好ましく;さらに
好ましくは炭素原子数1〜8の直鎖状又は分岐状のアル
キル基がよく;さらに好ましくは炭素原子数1〜4の直
鎖状のアルキル基がよい。[0013] As R2, an alkyl group (for example, a linear or branched one can be mentioned), a halogen atom (for example, the above-mentioned halogen atom can be mentioned; preferably a chlorine atom) preferred are alkyl groups; more preferably linear or branched alkyl groups having 1 to 8 carbon atoms; even more preferred are linear or branched alkyl groups having 1 to 4 carbon atoms. A chain alkyl group is preferable.
【0014】或いは、R2とR3とは、それらが結合し
ている炭素原子と共にピリミジン環に縮合して、硫黄原
子1個を有していてもよい飽和又は不飽和の5もしくは
6員環を形成していてもよく;好ましくはベンゼン環,
チオフェン環又はシクロペンタンを形成していてもよい
。Alternatively, R2 and R3 are fused together with the carbon atom to which they are bonded to a pyrimidine ring to form a saturated or unsaturated 5- or 6-membered ring which may have one sulfur atom. Preferably a benzene ring,
It may form a thiophene ring or cyclopentane.
【0015】R3としては、水素原子,アルキル基(例
えば、直鎖状又は分岐状のものを挙げることができるが
;好ましくは炭素原子数1〜8の直鎖状又は分岐状のも
のがよく;さらに好ましくは炭素原子数1〜4の直鎖状
のものがよい。),シクロアルキル基(例えば、炭素原
子数3〜6のものを挙げることができるが;好ましくは
シクロプロピル基がよい。),アルキルチオ基(例えば
、直鎖状又は分岐状のものを挙げることができるが;好
ましくは炭素原子数1〜8の直鎖状又は分岐状のものが
よく;さらに好ましくは炭素原子数1〜4の直鎖状のも
のがよい。),アルキル基で置換していてもよいアミノ
基(例えば、直鎖状又は分岐状のものを挙げることがで
きるが;好ましくは炭素原子数1〜8の直鎖状又は分岐
状のものがよく;さらに好ましくは炭素原子数1〜4の
直鎖状のものがよい。また、アルキル基で置換していて
もよいアミノ基では、好ましくはアルキル基で置換した
アミノ基がよい。)などを挙げることができるが;好ま
しくは水素原子がよい。R3 is a hydrogen atom or an alkyl group (for example, a linear or branched group; preferably a linear or branched group having 1 to 8 carbon atoms; More preferably, a linear one having 1 to 4 carbon atoms is preferable.), a cycloalkyl group (for example, one having 3 to 6 carbon atoms is preferable; a cyclopropyl group is preferable). , alkylthio group (for example, straight-chain or branched ones; preferably straight-chain or branched ones having 1 to 8 carbon atoms; more preferably 1 to 4 carbon atoms) ), an amino group which may be substituted with an alkyl group (for example, a straight chain or branched one; preferably a straight chain having 1 to 8 carbon atoms) A chain or branched one is preferable; a straight chain one having 1 to 4 carbon atoms is more preferable.In addition, for an amino group which may be substituted with an alkyl group, it is preferable to use an amino group substituted with an alkyl group. Preferably, a hydrogen atom is used.
【0016】R4としては、アルキル基,ハロアルキル
基(例えば、直鎖状又は分岐状のものを挙げることがで
きるが;好ましくは炭素原子数1〜8の直鎖状又は分岐
状のものがよく;さらに好ましくは炭素原子数1〜4の
直鎖状のものがよい。また、ハロゲン原子としては、好
ましくはフッ素原子がよい。),シクロアルキル基(例
えば、炭素原子数3〜6のものを挙げることができるが
;好ましくはシクロプロピル基がよい。),水素原子な
どを挙げることができるが;好ましくはアルキル基(例
えば、直鎖状又は分岐状のものを挙げることができるが
;好ましくは炭素原子数1〜8の直鎖状又は分岐状のも
のがよく;さらに好ましくは炭素原子数1〜4の直鎖状
のものがよい。),シクロアルキル基がよい。R4 is an alkyl group or a haloalkyl group (for example, a linear or branched group; preferably a linear or branched group having 1 to 8 carbon atoms; More preferably, a straight-chain one having 1 to 4 carbon atoms is preferable.The halogen atom is preferably a fluorine atom. (preferably a cyclopropyl group), a hydrogen atom, etc.; preferably an alkyl group (for example, a linear or branched group; preferably a carbon Straight chain or branched ones having 1 to 8 atoms are preferable; straight chain ones having 1 to 4 carbon atoms are more preferable.), and cycloalkyl groups are preferable.
【0017】R5としては、ハロゲン原子(例えば、前
記に記載したハロゲン原子を挙げることができるが;好
ましくはフッ素原子,臭素原子がよい。),水素原子な
どを挙げることができ;好ましくは水素原子がよい。Examples of R5 include halogen atoms (for example, the halogen atoms described above; preferably fluorine atoms and bromine atoms), hydrogen atoms, etc.; preferably hydrogen atoms. Good.
【0018】R6としては、水素原子,アルキル基(例
えば、直鎖状又は分岐状のものを挙げることができるが
;好ましくは炭素原子数1〜8の直鎖状又は分岐状のも
のがよく;さらに好ましくは炭素原子数1〜4の直鎖状
のものがよい。),ハロゲン原子(例えば、前記に記載
したハロゲン原子を挙げることができるが;好ましくは
塩素原子,フッ素原子がよい。),アルコキシ基(例え
ば、直鎖状又は分岐状のものを挙げることができるが;
好ましくは炭素原子数1〜8の直鎖状又は分岐状のもの
がよく;さらに好ましくは炭素原子数1〜4の直鎖状の
ものがよい。),ハロアルコキシ基(例えば、直鎖状又
は分岐状のものを挙げることができるが;好ましくは炭
素原子数1〜8の直鎖状又は分岐状のものがよく;さら
に好ましくは炭素原子数1〜4の直鎖状のものがよい。
また、ハロゲン原子としては、好ましくはフッ素原子が
よい。)などを挙げることができるが;好ましくは水素
原子がよい。R6 is a hydrogen atom or an alkyl group (for example, a linear or branched group; preferably a linear or branched group having 1 to 8 carbon atoms; More preferably, a linear one having 1 to 4 carbon atoms is preferable.), a halogen atom (for example, the halogen atoms described above can be mentioned; chlorine atoms and fluorine atoms are preferable), Alkoxy groups (for example, linear or branched ones can be mentioned;
Preferably, it is a straight chain or branched chain having 1 to 8 carbon atoms; more preferably a straight chain having 1 to 4 carbon atoms. ), haloalkoxy groups (for example, straight-chain or branched ones; preferably straight-chain or branched ones having 1 to 8 carbon atoms; more preferably 1 carbon atom) A straight-chain one of 4 to 4 is preferable.Also, as the halogen atom, a fluorine atom is preferable.Although, a hydrogen atom is preferable.
【0019】nとしては、1,2の整数を挙げることが
できる。[0019] As n, an integer of 1 or 2 can be listed.
【0020】Xとしては、特に限定されず、例えば、ハ
ロゲン原子(例えば、塩素,臭素又はヨウ素など。)、
アルキルチオ基(例えば、メチルチオ,エチルチオ,プ
ロピルチオ,ブチルチオなど)、ハロゲンで置換されて
いてもよいアルカンスルホニルオキシ基(例えば、メタ
ンスルホニルオキシ,エタンスルホニルオキシ,トリフ
ルオロメタンスルホニルオキシなど)、アリールスルホ
ニルオキシ基(例えば,ベンゼンスルホニルオキシ,p
−トルエンスルホニルオキシなど)、水酸基などを挙げ
ることができるが、好ましくはハロゲン原子がよく、さ
らに好ましくは塩素原子がよい。[0020] X is not particularly limited, and includes, for example, a halogen atom (for example, chlorine, bromine, or iodine),
Alkylthio groups (e.g., methylthio, ethylthio, propylthio, butylthio, etc.), alkanesulfonyloxy groups optionally substituted with halogen (e.g., methanesulfonyloxy, ethanesulfonyloxy, trifluoromethanesulfonyloxy, etc.), arylsulfonyloxy groups ( For example, benzenesulfonyloxy, p
-toluenesulfonyloxy, etc.), hydroxyl group, etc., preferably a halogen atom, and more preferably a chlorine atom.
【0021】置換基−OCF2R5の置換位置としては
、3−位,4−位を挙げることかできる。[0021] Examples of the substitution position of the substituent -OCF2R5 include the 3-position and the 4-position.
【0022】置換基−(R6)nの置換位置としては、
2−位,3−位,4−位,5−位を挙げることができる
が、好ましくは2−位,3−位,5−位がよい。目的化
合物〔化合物(3)〕は、アミノ基を有しているので容
易に酸付加塩を形成することができる。The substitution position of the substituent -(R6)n is as follows:
Examples include the 2-position, 3-position, 4-position, and 5-position, but preferably the 2-position, 3-position, and 5-position. Since the target compound [compound (3)] has an amino group, it can easily form an acid addition salt.
【0023】酸付加塩を形成する酸としては、例えば、
無機酸(塩酸,臭化水素酸,硝酸,硫酸,リン酸など)
、カルボン酸(ギ酸,シュウ酸,フマル酸,アジピン酸
,ステアリン酸,オレイン酸,アコニット酸など)、有
機スルホン酸(メタンスルホン酸,ベンゼンスルホン酸
,p−トルエンスルホン酸など)、サッカリンなどを挙
げることができる。Examples of acids that form acid addition salts include:
Inorganic acids (hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid, etc.)
, carboxylic acids (formic acid, oxalic acid, fumaric acid, adipic acid, stearic acid, oleic acid, aconitic acid, etc.), organic sulfonic acids (methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, etc.), saccharin, etc. be able to.
【0024】原料の化合物Bにおいて、*印の炭素原子
が不斉炭素原子であるときには、得られた目的の化合物
Cには、個々の光学異性体,ラセミ化合物又はそれらの
混合物が含まれる。When the carbon atom marked with * is an asymmetric carbon atom in the starting compound B, the obtained target compound C includes individual optical isomers, racemic compounds, or mixtures thereof.
【0025】本発明の化合物Cの合成は、通常、原料の
化合物Aと化合物Bとをアルコール溶媒中で加熱反応さ
せることによって行うことができる。本発明で用いる化
合物Aは、例えば、ジャーナル・オブ・ケミカル・ソサ
イエティ(J.Chem.Soc.)、3478〜34
81頁(1955年)に記載の方法に準じて、次式に示
すように行うことによって、容易に製造することができ
る。Compound C of the present invention can usually be synthesized by heating and reacting raw materials Compound A and Compound B in an alcohol solvent. Compound A used in the present invention is described, for example, in Journal of Chemical Society (J.Chem.Soc.), 3478-34.
It can be easily produced according to the method described on page 81 (1955) as shown in the following formula.
【0026】[0026]
【化7】[C7]
【0027】(式中、R1,R2及びR3は前記の記載
と同義である。)化合物Aとしては、例えば、表1〜8
中に示した化合物番号1〜61に対応した各置換基の種
類からなる各化合物(化合物A1〜A61と称する。)
を挙げることができる〔例えば、化合物番号1の化合物
Aを化合物A1と称す。そして、この化合物A1とは化
合物Aで示される式におけるR1が塩素原子,R2がエ
チル基,R3が水素原子であることを意味する。なお、
Xは脱離基であり、ここでは塩素原子である。〕。(In the formula, R1, R2 and R3 have the same meanings as described above.) As the compound A, for example, Tables 1 to 8
Compounds consisting of the types of substituents corresponding to compound numbers 1 to 61 shown therein (referred to as compounds A1 to A61).
For example, compound A with compound number 1 is referred to as compound A1. Compound A1 means that in the formula represented by compound A, R1 is a chlorine atom, R2 is an ethyl group, and R3 is a hydrogen atom. In addition,
X is a leaving group, here a chlorine atom. ].
【0028】本発明で用いる化合物Bは、例えば、ジャ
ーナル・オブ・アメリカン・ケミカル・ソサイエティ(
J.Amer.Chem.Soc.)、79巻、145
5頁(1957年)などに記載の方法に準じて、次式に
示すように行うことによって、容易に製造することがで
きる。Compound B used in the present invention is described, for example, in the Journal of the American Chemical Society (
J. Amer. Chem. Soc. ), vol. 79, 145
It can be easily produced by following the method shown in the following formula, in accordance with the method described in, for example, p. 5 (1957).
【0029】[0029]
【化8】[Chemical formula 8]
【0030】(式中、R4,R5,R6及びnは前記の
記載と同義である。)化合物Bとしては、例えば、表1
〜8中に示した化合物番号1〜61に対応した各置換基
の種類からなる各化合物(化合物B1〜B61と称する
。)を挙げることができる〔例えば、化合物番号1の化
合物Bを化合物B1と称す。そして、この化合物B1と
は化合物Bで示される式におけるR4がエチル基,R5
がフッ素原子,(R6)nが水素原子であることを意味
する。〕。(In the formula, R4, R5, R6 and n have the same meanings as described above.) As compound B, for example, Table 1
Compounds (referred to as compounds B1 to B61) consisting of the types of substituents corresponding to compound numbers 1 to 61 shown in ~8 can be mentioned [for example, compound B of compound number 1 can be referred to as compound B1]. It is called. This compound B1 is defined by the formula represented by compound B, in which R4 is an ethyl group and R5 is
means that is a fluorine atom and (R6)n is a hydrogen atom. ].
【0031】本発明では、ハロゲン化水素が発生するの
で、塩基を用いるのが好ましい。そして、そのような塩
基としては、例えば、トリエチルアミン,ピリジン,N
,N−ジメチルアニリンなどのような有機塩基;ナトリ
ウムメトキシド,ナトリウムエトキシドなどのようなア
ルカリ金属アルコキシド類;ナトリウムアミド,水酸化
ナトリウム,水酸化カリウム,炭酸カリウム,炭酸ナト
リウム,水素化ナトリウムなどの無機塩基などを挙げる
ことができる。In the present invention, since hydrogen halide is generated, it is preferable to use a base. Examples of such bases include triethylamine, pyridine, N
, N-dimethylaniline, etc.; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, etc.; sodium amide, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, sodium hydride, etc. Examples include inorganic bases.
【0032】本発明におけるアルコール溶媒としては、
例えば、メタノール,エタノール,n−プロパノール,
i−プロパノール,n−ブタノール,t−ブタノール,
エチレングリコールモノメチルエーテル,メチレングリ
コールモノエチルエーテル,ジエチレングリコールなど
のようなアルコール類又はその含水物;前記溶媒の混1
物などを挙げることができる。そして、その溶媒の使用
量は、化合物Bの濃度が5〜80重量%の濃度範囲にな
るようにして使用することができるが、好ましくは化合
物Bの濃度が10〜70重量%になるようにして使用す
るのがよい。[0032] As the alcohol solvent in the present invention,
For example, methanol, ethanol, n-propanol,
i-propanol, n-butanol, t-butanol,
Alcohols such as ethylene glycol monomethyl ether, methylene glycol monoethyl ether, diethylene glycol, etc. or their hydrates; mixtures of the above solvents;
Can list things. The amount of the solvent to be used can be such that the concentration of compound B is in the range of 5 to 80% by weight, but preferably the concentration of compound B is in the range of 10 to 70% by weight. It is better to use it.
【0033】原料化合物の使用量は、化合物Aに対して
化合物Bを0.3〜2倍モルで使用することができるが
、好ましくは0.5〜1.5倍モルで使用するのがよい
。[0033] Regarding the amount of the raw material compound to be used, Compound B can be used in an amount of 0.3 to 2 times the mole of Compound A, preferably 0.5 to 1.5 times in mole. .
【0034】反応温度は、好ましくは60〜200℃が
よく、さらに好ましくは70〜140℃である。The reaction temperature is preferably 60 to 200°C, more preferably 70 to 140°C.
【0035】反応時間は、前記の原料化合物の濃度、反
応温度によって変化するが、通常1〜4時間で行うこと
ができる。The reaction time varies depending on the concentration of the above-mentioned raw material compounds and the reaction temperature, but it can usually be carried out for 1 to 4 hours.
【0036】以上のようにして製造された目的の化合物
Cは、再結晶、各種クロマトグラフィーなどの公知の手
段で適宜精製することができる。そして、その酸付加塩
は、例えば、反応終了後の反応液中に酸を導入し、次に
、溶媒除去することによって、容易に得ることができる
。The target compound C produced as described above can be appropriately purified by known means such as recrystallization and various chromatography. The acid addition salt thereof can be easily obtained, for example, by introducing an acid into the reaction solution after the reaction is completed, and then removing the solvent.
【0037】化合物Cとしては、例えば、表1〜8中に
示した化合物番号1〜61に対応した各置換基の種類か
らなる各化合物(化合物C1〜C61と称する。)を挙
げることができる〔例えば、化合物番号1の化合物Cを
化合物C1と称す。そして、この化合物C1とは化合物
Cで示される式におけるR1が塩素原子,R2がエチル
基,R3が水素原子,R4がエチル基,R5がフッ素原
子,(R6)nが水素原子であることを意味する。〕。[0037] Examples of the compound C include compounds (referred to as compounds C1 to C61) having the types of substituents corresponding to compound numbers 1 to 61 shown in Tables 1 to 8. For example, compound C with compound number 1 is referred to as compound C1. This compound C1 is defined by the formula represented by compound C, in which R1 is a chlorine atom, R2 is an ethyl group, R3 is a hydrogen atom, R4 is an ethyl group, R5 is a fluorine atom, and (R6)n is a hydrogen atom. means. ].
【0038】[0038]
【実施例】以下、本発明の実施例を具体的に説明する。
なお、これらの実施例は、本発明の範囲を限定するもの
ではない。[Examples] Examples of the present invention will be explained in detail below. Note that these Examples do not limit the scope of the present invention.
【0039】実施例1
〔5−クロロ−6−メチル−4−(α−エチル−4−ジ
フルオロメトキシベンジルアミノ)ピリミジンの合成〕
Example 1 [Synthesis of 5-chloro-6-methyl-4-(α-ethyl-4-difluoromethoxybenzylamino)pyrimidine]
【0040】〔実施例〕■原料の化合物A4である4,
5−ジクロロ−6−メチルピリミジン1.6g(10m
mol)、原料の化合物B4であるdl−α−エチル−
4−ジフルオロメトキシベンジルアミン2.4g(12
mmol)及びトリエチルアミン1.8g(18mmo
l)をエタノール4.8mlに溶解し、7時間加熱還流
した。反応後、この反応混合物をトルエン30mlで3
回抽出し、ガスクロマトグラフィー内部標準法によって
目的の化合物C4を定量した結果(内部標準物質として
、1,2−ジクロロベンゼンを用いた。)、その収率は
90%であった。[Example] ■ 4, which is the raw material compound A4,
5-dichloro-6-methylpyrimidine 1.6g (10m
mol), dl-α-ethyl- which is the raw material compound B4
2.4 g (12
mmol) and triethylamine 1.8 g (18 mmol)
1) was dissolved in 4.8 ml of ethanol and heated under reflux for 7 hours. After the reaction, the reaction mixture was diluted with 30 ml of toluene.
The target compound C4 was extracted twice and quantified by gas chromatography internal standard method (1,2-dichlorobenzene was used as an internal standard substance), and the yield was 90%.
【0041】■前記■において、化合物B4を2.2g
(11mmol),トリエチルアミンを1.5g(15
mmol),エタノールを10mlとした以外は全て■
と同様にして化合物C4を合成した結果、その収率は9
0%であった。この合成法における反応の経時的変化を
図1に示す。■ In the above ■, 2.2 g of compound B4
(11 mmol), triethylamine 1.5 g (15
mmol), all except 10 ml of ethanol■
As a result of synthesizing compound C4 in the same manner as above, the yield was 9
It was 0%. Figure 1 shows the time course of the reaction in this synthetic method.
【0042】■前記■において、化合物B4を2.0g
(10mmol)とする以外は全て■と同様にして化合
物C4を合成した結果、その収率は86%であった。■ In the above ■, 2.0 g of compound B4
Compound C4 was synthesized in the same manner as in (2) except that the amount was changed to (10 mmol), and the yield was 86%.
【0043】〔比較例〕■前記■において、化合物B4
を2.2g(11mmol),トリエチルアミンを1.
5g(15mmol)とし、エタノールの代わりにトル
エンを10ml使用する以外は全て■と同様にして化合
物C4を合成した結果、その収率は69%であった。こ
の合成法における反応の経時的変化を図1に示す。[Comparative example] ■ In the above ■, compound B4
2.2g (11mmol) of triethylamine and 1.2g (11mmol) of triethylamine.
Compound C4 was synthesized in the same manner as in (2) except that the amount was 5 g (15 mmol) and 10 ml of toluene was used instead of ethanol, and the yield was 69%. Figure 1 shows the time course of the reaction in this synthetic method.
【0044】■前記■において、化合物B4を2.2g
(11mmol),トリエチルアミンを8.4g(84
mmol)とし、エタノールを用いずに90〜98℃で
加熱攪拌する以外は全て■と同様にして化合物C4を合
成した結果、その収率は46%であった。■ In the above ■, 2.2 g of compound B4
(11 mmol), 8.4 g (84 mmol) of triethylamine
Compound C4 was synthesized in the same manner as in (2) except that the compound C4 was heated and stirred at 90 to 98° C. without using ethanol, and the yield was 46%.
【0045】実施例2
〔5−クロロ−6−メチル−4−(α−メチル−4−ジ
フルオロメトキシベンジルアミノ)ピリミジンの合成〕
Example 2 [Synthesis of 5-chloro-6-methyl-4-(α-methyl-4-difluoromethoxybenzylamino)pyrimidine]
【0046】〔実施例〕■原料の化合物A23である4
,5−ジクロロ−6−メチルピリミジン1.6g(10
mmol)、原料の化合物B23であるdl−α−メチ
ル−4−ジフルオロメトキシベンジルアミン2g(11
mmol)及びトリエチルアミン1.5g(15mmo
l)をエタノール10m1に溶解し、3時間加熱還流し
た。反応後、この反応混合物をトルエン40mlで3回
抽出し、ガスクロマトグラフィー内部標準法によって目
的の化合物C23を定量した結果(内部標準物質として
、1,2−ジクロロベンゼンを用いた。)、その収率は
91%であった。[Example] ■ 4 which is the raw material compound A23
,5-dichloro-6-methylpyrimidine 1.6g (10
mmol), 2 g of dl-α-methyl-4-difluoromethoxybenzylamine (11
mmol) and triethylamine 1.5 g (15 mmol)
1) was dissolved in 10 ml of ethanol and heated under reflux for 3 hours. After the reaction, the reaction mixture was extracted three times with 40 ml of toluene, and the target compound C23 was quantified by gas chromatography internal standard method (1,2-dichlorobenzene was used as the internal standard substance). The rate was 91%.
【0047】〔比較例〕■前記■において、エタノール
の代わりにトルエンを使用する以外は全て■と同様にし
て化合物C23を合成した結果、その収率は55%であ
った。[Comparative Example] ■ Compound C23 was synthesized in the same manner as in ■ above except that toluene was used instead of ethanol, and the yield was 55%.
【0048】実施例3
〔5−クロロ−6−エチル−4−(α−エチル−4−ジ
フルオロメトキシベンジルアミノ)ピリミジンの合成〕
Example 3 [Synthesis of 5-chloro-6-ethyl-4-(α-ethyl-4-difluoromethoxybenzylamino)pyrimidine]
【0049】〔実施例〕■原料の化合物A3である4,
5−ジクロロ−6−エチルピリミジン1.8g(10m
mol)、原料の化合物B3であるdl−α−エチル−
4−ジフルオロメトキシベンジルアミン2.2g(11
mmol)及びトリエチルアミン1.5g(15mmo
l)をエタノール10mlに溶解し、3時間加熱還流し
た。反応後、この反応混合物をトルエン40mlで3回
抽出し、ガスクロマトグラフィー内部標準法によって目
的の化合物C3を定量した結果(内部標準物質として、
1,2−ジクロロベンゼンを用いた。)、その収率は8
8%であった。[Example] ■ 4, which is the raw material compound A3,
5-dichloro-6-ethylpyrimidine 1.8g (10m
mol), dl-α-ethyl- which is the raw material compound B3
2.2 g of 4-difluoromethoxybenzylamine (11
mmol) and triethylamine 1.5 g (15 mmol)
1) was dissolved in 10 ml of ethanol and heated under reflux for 3 hours. After the reaction, this reaction mixture was extracted three times with 40 ml of toluene, and the target compound C3 was quantified by gas chromatography internal standard method (as an internal standard substance,
1,2-dichlorobenzene was used. ), the yield is 8
It was 8%.
【0050】〔比較例〕■前記■において、エタノール
の代わりにトルエンを使用する以外は全て■と同様にし
て化合物C3を合成した結果、その収率は40%であっ
た。[Comparative Example] ■Compound C3 was synthesized in the same manner as in ■, except that toluene was used instead of ethanol, and the yield was 40%.
【0051】[0051]
【発明の効果】本発明によって、目的物であるアラルキ
ルアミノピリミジン類を短時間で合成することができ,
かつ高収率で得ることができる。[Effect of the invention] According to the present invention, the target aralkylaminopyrimidines can be synthesized in a short time.
and can be obtained in high yield.
【図1】実施例1におけるアルキルアミノピリミジンの
合成反応の経時的変化を示した説明図である。なお、●
−●は実施例■におけるピリミジン(A)の変換率(%
)を示し、○…○は比較例■におけるピリミジン(A)
の変換率(%)を示す。FIG. 1 is an explanatory diagram showing changes over time in the synthesis reaction of alkylaminopyrimidine in Example 1. In addition,●
−● is the conversion rate (%) of pyrimidine (A) in Example ■
), ○...○ indicates pyrimidine (A) in comparative example ■
The conversion rate (%) is shown.
【表1】[Table 1]
【表2】[Table 2]
【表3】[Table 3]
【表4】[Table 4]
【表5】[Table 5]
【表6】[Table 6]
【表7】[Table 7]
【表8】[Table 8]
Claims (1)
を表し;R2はアルキル基又はハロゲン原子を表し;或
いは、R1とR2とは、それらが結合している炭素原子
と共にピリミジン環に縮合して、硫黄原子1個を有して
いてもよい飽和又は不飽和の5もしくは6員環を形成し
ていてもよく;R3は水素原子,アルキル基,シクロア
ルキル基,アルキルチオ基又はアルキル基で置換してい
てもよいアミノ基を表し;Xは脱離基を表す。)で示さ
れるピリミジン類と 次式: 【化2】 (式中、R4はアルキル基,ハロアルキル基,シクロア
ルキル基又は水素原子を表し;R5はハロゲン原子又は
水素原子を表し;R6は水素原子,アルキル基,ハロゲ
ン原子,アルコキシ基,ハロアルコキシ基を表し;nは
1又は2を表す。)で示されるアラルキルアミン類とを
アルコール溶媒中で反応させることを特徴とする次式: 【化3】 (式中、R1,R2,R3,R4,R5,R6及びnは
前記の記載と同義。)で示されるアラルキルアミノピリ
ミジン類の製法。Claim 1: The following formula: [Formula 1] (In the formula, R1 represents a halogen atom, an alkyl group, or a hydrogen atom; R2 represents an alkyl group or a halogen atom; or R1 and R2 are bonded together. may be fused to the pyrimidine ring with the carbon atom of represents a cycloalkyl group, an alkylthio group, or an amino group which may be substituted with an alkyl group; X represents a leaving group) and the pyrimidines represented by the following formula: R5 represents a halogen atom or a hydrogen atom; R6 represents a hydrogen atom, an alkyl group, a halogen atom, an alkoxy group, a haloalkoxy group; n represents 1 or 2; ) is reacted with an aralkylamine represented by the following formula in an alcohol solvent: Synonymous with ).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3073547A JP2762430B2 (en) | 1991-01-18 | 1991-01-18 | Preparation of aralkylaminopyrimidines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3073547A JP2762430B2 (en) | 1991-01-18 | 1991-01-18 | Preparation of aralkylaminopyrimidines |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04235976A true JPH04235976A (en) | 1992-08-25 |
JP2762430B2 JP2762430B2 (en) | 1998-06-04 |
Family
ID=13521372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3073547A Expired - Lifetime JP2762430B2 (en) | 1991-01-18 | 1991-01-18 | Preparation of aralkylaminopyrimidines |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2762430B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049689A1 (en) * | 1996-06-21 | 1997-12-31 | Pharmacia & Upjohn S.P.A. | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
WO2000012487A1 (en) * | 1998-08-27 | 2000-03-09 | Sumitomo Pharmaceuticals Co., Ltd. | Pyrimidine derivatives |
US6084095A (en) * | 1994-01-25 | 2000-07-04 | Warner-Lambert Company | Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6596726B1 (en) | 1994-01-25 | 2003-07-22 | Warner Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US7601725B2 (en) | 2004-07-16 | 2009-10-13 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006047397A1 (en) | 2004-10-21 | 2006-05-04 | Dow Agrosciences Llc | Thieno-pyrimidine compounds having fungicidal activity |
US7531482B2 (en) | 2005-10-21 | 2009-05-12 | Dow Agrosciences Llc | Thieno-pyrimidine compounds having fungicidal activity |
-
1991
- 1991-01-18 JP JP3073547A patent/JP2762430B2/en not_active Expired - Lifetime
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6713484B2 (en) | 1994-01-25 | 2004-03-30 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6084095A (en) * | 1994-01-25 | 2000-07-04 | Warner-Lambert Company | Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6265410B1 (en) | 1994-01-25 | 2001-07-24 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6455534B2 (en) | 1994-01-25 | 2002-09-24 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6521620B1 (en) | 1994-01-25 | 2003-02-18 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6596726B1 (en) | 1994-01-25 | 2003-07-22 | Warner Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
US6057326A (en) * | 1996-06-21 | 2000-05-02 | Pharmacia & Upjohn S.P.A | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
WO1997049689A1 (en) * | 1996-06-21 | 1997-12-31 | Pharmacia & Upjohn S.P.A. | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
WO2000012487A1 (en) * | 1998-08-27 | 2000-03-09 | Sumitomo Pharmaceuticals Co., Ltd. | Pyrimidine derivatives |
US6458798B1 (en) | 1998-08-27 | 2002-10-01 | Sumitomo Pharmaceuticals Company, Limited | Bicyclic pyrimidine compounds and therapeutic use thereof |
US6951866B2 (en) | 1998-08-27 | 2005-10-04 | Sumitomo Pharmaceuticals Company, Limited | Bicyclic pyrimidine compounds and therapeutic use thereof |
JP4497340B2 (en) * | 1998-08-27 | 2010-07-07 | 大日本住友製薬株式会社 | Pyrimidine derivatives |
US7601725B2 (en) | 2004-07-16 | 2009-10-13 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
JP2762430B2 (en) | 1998-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940001774B1 (en) | Pyridine-2,3-dicarboxylate esters | |
AU2002250962B2 (en) | Process for the preparation of mesylates of piperazine derivatives | |
JPH04235976A (en) | Production of aralkylaminopyrimidine compounds | |
JPS59122470A (en) | Preparation of quinoline-3-carboxylic acid derivative | |
JPH03120279A (en) | Novel method | |
RU2512567C2 (en) | Phenyl alkyl piperazines, which modulate tnf activity | |
JP2007308510A (en) | Derivative of 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyl chloride, its production method, and its use as synthetic intermediate | |
JP4636525B2 (en) | Salt of trans-4-amino-1-cyclohexanecarboxylic acid ethyl ester and process for producing the same | |
RU2116305C1 (en) | Method of synthesis of 2-{4-[4-(4-chloro-1-pyrazolyl)butyl]-1-piperazinyl}-pyrimidine (lezopitron) | |
JP2002105058A (en) | Method for manufacturing 1,3-dialkylimidazolium iodide salt | |
JPH11130752A (en) | Production of heteroaryl carboxylic amide and ester | |
JPH02289563A (en) | Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones | |
JPWO2006083010A1 (en) | Method for producing 4-acetylpyrimidine compound and crystal thereof | |
IE911180A1 (en) | Process for preparing pyridine and quinoline derivatives | |
JP2002220371A (en) | Method for producing n-vinyl carbazoles | |
JPS6117557A (en) | Manufacture of amine derivative | |
HU195485B (en) | Process for producing aromatic carboxylic acid derivatives and -carboxamide derivatives | |
TWI286130B (en) | Method for the production of gamma-keto-acetals | |
US6762303B2 (en) | Method for producing pyridine compounds | |
JPH03178959A (en) | Production of bisalkylsulfonomethyl ethers or bisarylsulfonoxymethyl ethers | |
JPH04283524A (en) | Production of trifluoromethyl-substituted aromatic compound | |
JPH02145578A (en) | Production of acylmorpholide | |
JPH10212276A (en) | Production of acid chloride compound | |
JPWO2007086559A1 (en) | Method for producing tetrahydropyran compound | |
JP2018140944A (en) | Method for producing pyrazole compound and intermediate thereof |